IntrepidiaBio
IntrepidaBio is a preclinical biotechnology company dedicated to developing cures for cancer and other diseases through drugs that alter the body’s first line of defense, innate immunity.
Partner
Nina KjellsonInvestment
Series A
IntrepidaBio is a preclinical biotechnology company dedicated to developing cures for cancer and other diseases through drugs that alter the body’s first line of defense, innate immunity.
Series A